Marlene Dufresne

Toulouse, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

The TRIP12's intrinsically disordered region induces chromatin condensates and interferes with nuclear processes.

The TRIP12's intrinsically disordered region induces chromatin condensates and interferes with nuclear processes.

Journal: iScience
Published: May 17, 2025

The E3 ubiquitin ligase TRIP12 is required for pancreatic acinar cell plasticity and pancreatic carcinogenesis.

The E3 ubiquitin ligase TRIP12 is required for pancreatic acinar cell plasticity and pancreatic carcinogenesis.

Journal: The Journal of pathology
Published: November 14, 2023

Upregulated Apelin Signaling in Pancreatic Cancer Activates Oncogenic Signaling Pathways to Promote Tumor Development.

Upregulated Apelin Signaling in Pancreatic Cancer Activates Oncogenic Signaling Pathways to Promote Tumor Development.

Journal: International journal of molecular sciences
Published: July 28, 2022

E3 Ubiquitin Ligase TRIP12: Regulation, Structure, and Physiopathological Functions.

E3 Ubiquitin Ligase TRIP12: Regulation, Structure, and Physiopathological Functions.

Journal: International journal of molecular sciences
Published: September 25, 2020

The E3 ubiquitin ligase TRIP12 participates in cell cycle progression and chromosome stability.

The E3 ubiquitin ligase TRIP12 participates in cell cycle progression and chromosome stability.

Journal: Scientific reports
Published: September 23, 2019

Experimental pancreatic cancer develops in soft pancreas: novel leads for an individualized diagnosis by ultrafast elasticity imaging.

Experimental pancreatic cancer develops in soft pancreas: novel leads for an individualized diagnosis by ultrafast elasticity imaging.

Journal: Theranostics
Published: February 13, 2019

Advance in the biology of pancreatic of cancer

Advance in the biology of pancreatic of cancer

Journal: Bulletin du cancer
Published: April 01, 2015

First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings.

First-in-man phase 1 clinical trial of gene therapy for advanced pancreatic cancer: safety, biodistribution, and preliminary clinical findings.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 09, 2014

Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110α.

Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110α.

Journal: Genes & development
Published: December 03, 2014

The E3 ubiquitin ligase thyroid hormone receptor-interacting protein 12 targets pancreas transcription factor 1a for proteasomal degradation.

The E3 ubiquitin ligase thyroid hormone receptor-interacting protein 12 targets pancreas transcription factor 1a for proteasomal degradation.

Journal: The Journal of biological chemistry
Published: October 31, 2014

Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.

Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.

Journal: Gastroenterology
Published: April 11, 2014

Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.

Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.

Journal: British journal of cancer
Published: March 27, 2014
Showing 1-12 of 16

Last Updated: 09/26/2026